Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junko Murai

Showing results (11-20 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|July 23, 2008
Smad7 Inhibits chondrocyte differentiation at multiple steps during endochondral bone formation and down-regulates p38 MAPK pathwaysTakao Iwai, Junko Murai, Hideki Yoshikawa, et al.
The Journal of Biological Chemistry|August 7, 2008
Insulation of the ubiquitous Rxrb promoter from the cartilage-specific adjacent gene, Col11a2Junko Murai, Daisuke Ikegami, Mina Okamoto, et al.
Iscience|October 25, 2021
Schlafen 11 expression in human acute leukemia cells with gain-of-function mutations in the interferon-JAK signaling pathwayYasuhisa Murai, Ukhyun Jo, Junko Murai, et al.
Development, Growth & Differentiation|December 17, 2010
Asymmetric inhibition of spicule formation in sea urchin embryos with low concentrations of gadolinium ionMotoshi Saitoh, Ritsu Kuroda, Yoshinori Muranaka, et al.
Molecular and Cellular Biology|April 13, 2011
The USP1/UAF1 complex promotes double-strand break repair through homologous recombinationJunko Murai, Kailin Yang, Donniphat Dejsuphong, et al.
Scientific Reports|June 30, 2021
De novo deoxyribonucleotide biosynthesis regulates cell growth and tumor progression in small-cell lung carcinomaAmi Maruyama, Yuzo Sato, Joji Nakayama, et al.
NAR Cancer|October 9, 2025
Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphomaTakatoshi Shimauchi, Junko Murai, Manami Iwasaki, et al.
Journal of Ovarian Research|April 23, 2026
Dynamic changes in homologous recombination status before and after chemotherapy in advanced ovarian, fallopian tube, and primary peritoneal cancersAkemi Morimoto, Takashi Matsumoto, Norifumi Teramoto, et al.
Genes & Development|September 8, 2011
Regulation of the Fanconi anemia pathway by a SUMO-like delivery networkKailin Yang, George-Lucian Moldovan, Patrizia Vinciguerra, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2014
Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibitionJunko Murai, Yiping Zhang, Joel Morris, et al.
Pageof 8

Showing results (11-20 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|July 23, 2008
Smad7 Inhibits chondrocyte differentiation at multiple steps during endochondral bone formation and down-regulates p38 MAPK pathwaysTakao Iwai, Junko Murai, Hideki Yoshikawa, et al.
The Journal of Biological Chemistry|August 7, 2008
Insulation of the ubiquitous Rxrb promoter from the cartilage-specific adjacent gene, Col11a2Junko Murai, Daisuke Ikegami, Mina Okamoto, et al.
Iscience|October 25, 2021
Schlafen 11 expression in human acute leukemia cells with gain-of-function mutations in the interferon-JAK signaling pathwayYasuhisa Murai, Ukhyun Jo, Junko Murai, et al.
Development, Growth & Differentiation|December 17, 2010
Asymmetric inhibition of spicule formation in sea urchin embryos with low concentrations of gadolinium ionMotoshi Saitoh, Ritsu Kuroda, Yoshinori Muranaka, et al.
Molecular and Cellular Biology|April 13, 2011
The USP1/UAF1 complex promotes double-strand break repair through homologous recombinationJunko Murai, Kailin Yang, Donniphat Dejsuphong, et al.
Scientific Reports|June 30, 2021
De novo deoxyribonucleotide biosynthesis regulates cell growth and tumor progression in small-cell lung carcinomaAmi Maruyama, Yuzo Sato, Joji Nakayama, et al.
NAR Cancer|October 9, 2025
Co-expression of CD30 and SLFN11 serves as a dual biomarker for the treatment of cutaneous T-cell lymphomaTakatoshi Shimauchi, Junko Murai, Manami Iwasaki, et al.
Journal of Ovarian Research|April 23, 2026
Dynamic changes in homologous recombination status before and after chemotherapy in advanced ovarian, fallopian tube, and primary peritoneal cancersAkemi Morimoto, Takashi Matsumoto, Norifumi Teramoto, et al.
Genes & Development|September 8, 2011
Regulation of the Fanconi anemia pathway by a SUMO-like delivery networkKailin Yang, George-Lucian Moldovan, Patrizia Vinciguerra, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2014
Rationale for poly(ADP-ribose) polymerase (PARP) inhibitors in combination therapy with camptothecins or temozolomide based on PARP trapping versus catalytic inhibitionJunko Murai, Yiping Zhang, Joel Morris, et al.
Pageof 8